Comparison between Supriya Lifescience IPO and Tracxn Technologies IPO.
Supriya Lifescience IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Tracxn Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Supriya Lifescience IPO is up to ₹700.00 Cr whereas the issue size of the Tracxn Technologies IPO is up to ₹309.38 Cr. The final issue price of Supriya Lifescience IPO is ₹274.00 per share and of Tracxn Technologies IPO is ₹80.00 per share.
| Supriya Lifescience IPO | Tracxn Technologies IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ₹265.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹274.00 per share | ₹80.00 per share |
| Issue Price (Final) | ₹274.00 per share | ₹80.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 54 shares | 185 shares |
| Fresh Issue Size | 72,99,270 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹200.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 1,82,48,175 shares | 3,86,72,208 shares |
| OFS Issue Size (Amount) | up to ₹500.00 Cr | up to ₹309.38 Cr |
| Issue Size Total | 2,55,47,445 shares | 3,86,72,208 shares |
| Issue Size Total (Amount) | up to ₹700.00 Cr | up to ₹309.38 Cr |
Supriya Lifescience IPO opens on Dec 16, 2021, while Tracxn Technologies IPO opens on Oct 10, 2022. The closing date of Supriya Lifescience IPO and Tracxn Technologies IPO is Dec 20, 2021, and Oct 12, 2022, respectively.
| Supriya Lifescience IPO | Tracxn Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Dec 15, 2021 | Oct 07, 2022 |
| Issue Open | Dec 16, 2021 | Oct 10, 2022 |
| Issue Close | Dec 20, 2021 | Oct 12, 2022 |
| Basis Of Allotment (Tentative) | Dec 23, 2021 | Oct 17, 2022 |
| Initiation of Refunds (Tentative) | Dec 24, 2021 | Oct 18, 2022 |
| Credit of Share (Tentative) | Dec 27, 2021 | Oct 19, 2022 |
| Listing date (Tentative) | Dec 28, 2021 | Oct 20, 2022 |
| Anchor Lockin End date 1 | Jan 22, 2022 | Nov 16, 2022 |
| Anchor Lockin End date 2 | Mar 23, 2022 | Jan 15, 2023 |
Supriya Lifescience IPO P/E ratio is , as compared to Tracxn Technologies IPO P/E ratio of 240.
| Supriya Lifescience IPO | Tracxn Technologies IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.98 | 50.93 | ||||
| Promoter Shareholding (Post-Issue) | 68.24 | 35.65 | ||||
| P/E Ratio | 240 | |||||
| Market Cap | ₹700.00 Cr. | ₹802.48 Cr. | ||||
| ROE | -24 | |||||
| ROCE | -28 | |||||
| Debt/Equity | ||||||
| EPS | ₹-0.48 | |||||
| RoNW | -23.49 |
In the Supriya Lifescience IPO Retail Individual Investors (RII) are offered 25,54,744 shares while in Tracxn Technologies IPO retail investors are offered 25,54,744 shares. Qualified Institutional Buyers (QIB) are offered 76,64,234 shares in Supriya Lifescience IPO and 1,16,01,663 shares in Tracxn Technologies IPO.
| Supriya Lifescience IPO | Tracxn Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,14,96,351 shares | 1,74,02,494 shares |
| Market Maker Reservation | ||
| QIB | 76,64,234 shares | 1,16,01,663 shares |
| NII | 38,32,116 shares | 58,00,831 shares |
| RII | 25,54,744 shares | 38,67,220 shares |
| Employee | ||
| Others | ||
| Total | 2,55,47,445 shares | 3,86,72,208 shares |
Supriya Lifescience IPO subscribed 71.51x in total, whereas Tracxn Technologies IPO subscribed 2.01x.
| Supriya Lifescience IPO | Tracxn Technologies IPO | |
|---|---|---|
| QIB (times) | 31.83x | 1.66x |
| NII (times) | 161.22x | 0.80x |
| Big NII (times) | 0.72x | |
| Small NII (times) | 0.94x | |
| RII (times) | 56.01x | 4.87x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 71.51x | 2.01x |
